MFAP3L activation promotes colorectal cancer cell invasion and metastasis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 9, 2014, Pages 1423-1432

  Lou, Xiaomin ^a   Kang, Bin ^a   Zhang, Jun ^a   Hao, Chunyi ^b   Tian, Xiuyun ^b   Li, Wenmei ^b   Xu, Ningzhi ^c   Lu, Youyong ^b   Liu, Siqi ^a  

^a Chinese Academy of Sciences and China National Center for Bioinformation   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^c CANCER HOSPITAL   (China)

Author keywords

Colorectal cancer; Metastasis; MFAP3L; Protein kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOPROTEIN; MFAP3L PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE; PROTEIN SH2; UNCLASSIFIED DRUG; MICROFIBRIL ASSOCIATED GLYCOPROTEIN 3 LIKE; MITOGEN ACTIVATED PROTEIN KINASE 1; THREONINE; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL FRACTIONATION; CELL INVASION; COLORECTAL CARCINOMA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISTANT METASTASIS; ENZYME ACTIVATION; ENZYME ACTIVE SITE; FEMALE; GENE SILENCING; GENE TRANSLOCATION; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; WILD TYPE; ANIMAL TISSUE; CELL STIMULATION; CELLULAR DISTRIBUTION; COLORECTAL CANCER; GENE EXPRESSION; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

COLORECTAL CANCER; METASTASIS; MFAP3L; PROTEIN KINASE;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CLONING, MOLECULAR; COLORECTAL NEOPLASMS; CONTRACTILE PROTEINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; NEOPLASM INVASIVENESS; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; WOUND HEALING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84903472870     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.04.006     Document Type: Article

References (26)

1. Haig R.Y., Merne M., Hansson A., Zheng X., Roberg K., Nees M., Iljin K., Bloor B.K., Morgan P.R., Fadeel B., Grafström R.C. Differentiation-promoting culture of competent and noncompetent keratinocytes identifies biomarkers for head and neck cancer. Am. J. Pathol. 2011, 180:457-472.
2. Albig A.R., Becenti D.J., Roy T.G., Schiemann W.P. Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cells. Microvasc. Res. 2008, 76:7-14.
3. Mok S.C., Bonome T., Vathipadiekal V., Bell A., Johnson M.E., Wong K.K., Park D.C., Hao K., Yip D.K., Donninger H., Ozbun L., Samimi G., Brady J., Randonovich M., Pise-Masison C.A., Barrett J.C., Wong W.H., Welch W.R., Berkowitz R.S., Birrer M.J. A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell 2009, 16:521-532.
4. Spivey K.A., Banyard J. A prognostic gene signature in advanced ovarian cancer reveals a microfibril-associated protein (MAGP2) as a promoter of tumor cell survival and angiogenesis. Cell Adhes. Migr. 2010, 4:169-171.
5. Kang B., Hao C., Wang H., Zhang J., Xing R., Shao J., Li W., Xu N., Lu Y., Liu S. Evaluation of hepatic-metastasis risk of colorectal cancer upon the protein signature of PI3K/AKT pathway. J. Proteome Res. 2008, 7:3507-3515.
6. Wu J.H., Tian X.Y., Hao C.Y. The significance of a group of molecular markers and clinicopathological factors in identifying colorectal liver metastasis. Hepatogastroenterology 2011, 58:1182-1188.
7. Xiao J., Yin L., Li J., Zu H., Zhou Z., Zhao B., Sha J. Molecular cloning, identification and characteristics of NYD-SP9: gene coding protein kinase presumably involved in spermatogenesis. Chin. Sci. Bull. 2002, 47:896-901.
8. Wells A. Tumor invasion: role of growth factor-induced cell motility. Adv. Cancer Res. 2000, 78:31-101.
9. Citri A., Yarden Y. EGF-ERBB signalling: towards the systems level. Nat. Rev. Mol. Cell Biol. 2006, 7:505-516.
10. Cao H., Lei Z.M., Bian L., Rao C.V. Functional nuclear epidermal growth factor receptors in human choriocarcinoma JEG-3 cells and normal human placenta. Endocrinology 1995, 136:3163-3172.
11. Psyrri A., Yu Z., Weinberger P.M., Sasaki C., Haffty B., Camp R., Rimm D., Burtness B.A. Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis. Clin. Cancer Res. 2005, 11:5856-5862.
12. Lin S.Y., Makino K., Xia W., Matin A., Wen Y., Kwong K.Y., Bourguignon L., Hung M.C. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat. Cell Biol. 2001, 3:802-808.
13. Lo H.W., Xia W., Wei Y., Ali-Seyed M., Huang S.F., Hung M.C. Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res. 2005, 65:338-348.
14. Zampieri C.A., Fortin J.F., Nolan G.P., Nabel G.J. The ERK mitogen-activated protein kinase pathway contributes to Ebola virus glycoprotein-induced cytotoxicity. J. Virol. 2007, 81:1230-1240.
15. Lo H.W., Hsu S.C., Ali-Seyed M., Gunduz M., Xia W., Wei Y., Bartholomeusz G., Shih J.Y., Hung M.C. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 2005, 7:75-89.
16. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 2001, 22:153-183.
17. Haycock J.W. Peptide substrates for ERK1/2: structure-function studies of serine 31 in tyrosine hydroxylase. J. Neurosci. Methods 2002, 116:29-34.
18. Lee J.W., Juliano R. Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways. Mol. Cells 2004, 17:188-202.
19. Okada Y., Eibl G., Guha S., Duffy J.P., Reber H.A., Hines O.J. Nerve growth factor stimulates MMP-2 expression and activity and increases invasion by human pancreatic cancer cells. Clin. Exp. Metastasis 2004, 21:285-292.
20. Silletti S., Yebra M., Perez B., Cirulli V., McMahon M., Montgomery A.M. Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J. Biol. Chem. 2004, 279:28880-28888.
21. Miyamoto A., Lau R., Hein P.W., Shipley J.M., Weinmaster G. Microfibrillar proteins MAGP-1 and MAGP-2 induce Notch1 extracellular domain dissociation and receptor activation. J. Biol. Chem. 2006, 281:10089-10097.
22. Vermeulen L., De Wilde G., Van Damme P., Vanden Berghe W., Haegeman G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 2003, 22:1313-1324.
23. Brondello J.M., Brunet A., Pouyssegur J., McKenzie F.R. The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J. Biol. Chem. 1997, 272:1368-1376.
24. Costa M., Marchi M., Cardarelli F., Roy A., Beltram F., Maffei L., Ratto G.M. Dynamic regulation of ERK2 nuclear translocation and mobility in living cells. J. Cell Sci. 2006, 119:4952-4963.
25. Carpenter G. Nuclear localization and possible functions of receptor tyrosine kinases. Curr. Opin. Cell Biol. 2003, 15:143-148.
26. Schlessinger J., Lemmon M.A. Nuclear signaling by receptor tyrosine kinases: the first robin of spring. Cell 2006, 127:45-48.